PKCδ, an isoform of novel PKC, acts as a critical mediator of the maintenance of tumor stem cells through an autocrine loop with positive feedback that is driven by the PKCδ/STAT3/IL-23/JAK signaling axis (103). Here, PRRT2 is linked to neoplasm.